HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Wednesday, 23 February 2011

Recent cost utility studies

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 24  papers were listed this time. We've singled out a methods paper on QALY imputation, a value of information analysis, a couple of meta-analyses with associated economic evaluations and an evaluation in Type 1 diabetes:

Purmonen TT, P Nk L Inen E, Turunen JH, Asseburg et al. Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial. Acta Oncol. 2011 Feb 8. [Epub ahead of print] PMID: 21299447.

Jeroen L, Christiaan M, Niel H, et al. Imputing QALYs from Single Time Point Health State Descriptions on the EQ-5D and the SF-6D:  A Comparison of Methods for Hepatitis A Patients. Value Health. 2011 Feb 4. [Epub ahead of print] PMID: 21296602.

Grosso AM, Bodalia PN, Macallister RJ, et al. Comparative clinical- and cost-effectiveness of candesartan and losartan in the management of hypertension and heart failure: a systematic review, meta- and cost-utility analysis. Int J Clin Pract. 2011 Mar;65(3):253-63. PMID: 21284790.

Klersy C, De Silvestri A, Gabutti G, et al. Economic impact of remote patient monitoring: an integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure. Eur J Heart Fail. 2011 Feb 1. [Epub ahead of print] PMID: 21193439.

Valentine WJ, Aagren M, Haglund M, et al. Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in  Sweden. Scand J Public Health. 2011 Feb;39(1):79-87. PMID: 20688795.